Obesity was associated with a higher cumulative incidence of cardiovascular outcomes compared with a matched general population, notably for heart failure hospitalisation (HR 2.34; 95% CI 2.29-2.40).
Cohort
Does obesity increase the risk of long-term cardiovascular outcomes compared to a matched general population in Swedish clinical practice?
Obesity remains significantly underdiagnosed and undertreated in real-world practice, despite being associated with a substantially higher risk of long-term cardiovascular outcomes, particularly heart failure hospitalization.
Estimación del efecto: HR 2.34 (95% CI 2.29-2.40)
AIMS: To quantify real-world diagnosis and treatment of obesity in Sweden, describe cardiometabolic comorbidity burden across obesity classes, and compare long-term cardiovascular outcomes with the general population. MATERIALS AND METHODS: , cardiometabolic comorbidity profiles, treatment patterns and long-term cardiovascular outcomes. Cardiovascular outcomes were compared with a matched general population. RESULTS: (index), 28.8% had a recorded obesity diagnosis, increasing to 48.0% 5 years later. Index BMI was most often recorded in primary care (39.7%). Within 5 years after index, 7.8% had received obesity-management medication and 4.2% had undergone bariatric surgery. Compared with matched population representatives, the obesity cohort had higher cumulative incidence across all cardiovascular outcomes, with the largest relative difference for heart failure hospitalisation (HR 2.34, 95% CI 2.29-2.40). CONCLUSIONS: Obesity remains underdiagnosed and undertreated in Swedish healthcare, despite a high burden of cardiometabolic comorbidities and substantially higher long-term cardiovascular risk compared with the general population.
Ritsinger et al. (Wed,) conducted a cohort in Obesity. Obesity vs. Matched general population was evaluated on Heart failure hospitalisation (HR 2.34, 95% CI 2.29-2.40). Obesity was associated with a higher cumulative incidence of cardiovascular outcomes compared with a matched general population, notably for heart failure hospitalisation (HR 2.34; 95% CI 2.29-2.40).